Cargando…
An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal Study
Strong evidence suggests that genetic variations in DNA methyltransferases (DNMTs) may alter the downstream expression and DNA methylation patterns of neuronal genes and influence cognition. This study investigates the association between a DNMT1 polymorphism, rs2162560, and chemotherapy-associated...
Autores principales: | Chan, Alexandre, Yeo, Angie, Shwe, Maung, Tan, Chia Jie, Foo, Koon Mian, Chu, Pat, Khor, Chiea Chuen, Ho, Han Kiat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787348/ https://www.ncbi.nlm.nih.gov/pubmed/31601979 http://dx.doi.org/10.1038/s41598-019-51203-y |
Ejemplares similares
-
Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study
por: Ng, Terence, et al.
Publicado: (2017) -
Association of plasma leptin, pro‐inflammatory adipokines and cancer‐related fatigue in early‐stage breast cancer patients: A prospective cohort study
por: Toh, Yi Long, et al.
Publicado: (2019) -
Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy
por: Tan, Chia Jie, et al.
Publicado: (2018) -
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer
por: Ng, Terence, et al.
Publicado: (2016) -
Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer‐Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy
por: Toh, Yi Long, et al.
Publicado: (2019)